Our Singapore hub accelerates your timelines with comprehensive laboratory services that simplify logistics across the Asia-Pacific (APAC) region through:
Reliable, high-quality data that meets global regulatory compliance standards
Consistent global standard operating procedures (SOPs), platforms, and standards across central and bioanalysis laboratories
Rapid turnarounds that keep your trial milestone targets on track
With Labcorp, you gain a trusted laboratory partner to navigate clinical research complexities, helping bring innovative therapies to patients faster.
Learn more about our capabilities in Singapore.
Starting with a central laboratory in 2000, Labcorp has grown a strong presence in Singapore. In 2021, we enhanced these capabilities with the launch of a state-of-the-art bioanalysis laboratory, which we expanded in 2025. Today, our combined laboratory facilities span over 7,300 m2, more than 12 times the size of our original facility.
Our laboratories operate under globally aligned SOPs, relying on industry-leading science and technical platforms to drive global data combinability for your clinical trials, crucial for international research and drug development.
BSL-2 Laboratory certification
College of American Pathologists (CAP) accreditation
Laboratory Certification for National Glycohemoglobin Standardization Program (NGSP)
CAP ISO 15189 accreditation
Healthcare Services Act (HCSA) license by Singapore Ministry of Health
Certification on compliance to Organisation for Economic Co-operation and Development (OECD) Principles of Good Laboratory Practice
The Singapore central laboratory services team comes with 25 years of experience delivering high-quality, consistent data across 14 countries/regions in the Asia-Pacific area. Our central lab spans more than 6,300 m2 and offers an extensive assay menu for comprehensive clinical trial testing solutions, going beyond basic chemistry and safety to highly specialized testing that includes:
.gif_%3b%20filename_%3dutf-8%27%27anatomical-pathology-and-histology-%2528aph%2529.gif)
In Singapore, our central lab team supports over 2,500 active global studies, including over 40 companion diagnostics (CDx) studies annually. We work on more than 40 new validations every year, adding to hundreds of biomarkers.
Spanning over 1,000 m2, our bioanalytical facility offers comprehensive capabilities including method development, method validation, and sample analysis for both preclinical and clinical studies. To support the scientific quality of your studies, we adhere to GLP and GCP standards, providing small molecule analytical services, large molecule analytical services, and clinical biomarker analytical services.
LC-MS/MS platforms
For small molecule analytical services, you can rely on a team that’s developed:
Our capabilities cover small molecule compounds, ADCs, peptides, chiral compounds, biomarkers, endogenous compounds and more.
Immunochemistry platforms (ELISA, MSD, Gyros, PCR and cell-based)
For large molecule analytical services, we offer:
Our capabilities extend to monoclonal antibodies, bispecific antibodies, ADCs, peptides, fusion proteins, biomarkers, vaccines and more.
Various compounds, types and platforms
Get the comprehensive coverage you need to accelerate research with our biomarker analytical services that encompass several compounds and technology platforms dedicated to the exploration and validation of biomarkers.
Compounds | Types | Technology Platforms |
|
|
|
Our capabilities extend to monoclonal antibodies, bispecific antibodies, ADCs, peptides, fusion proteins, biomarkers, vaccines and more.
Sales/general enquiries:
+65 6568 6588
Email: apacmarketing@labcorp.com
Labcorp Development (Asia) Pte. Ltd.
1 International Business Park,
#02-13 The Synergy,
Singapore 609917
Info Sheet
Antibody-drug conjugates (ADCs) continue to be a widely used and key modality of interest for the pharmaceutical industry due to their ability to deliver targeted cytotoxic payloads.
Breathe easy. With our expanded state-of-the-art facility, dedicated inhalation testing rooms and team of 40 experienced specialists.
Expanded Commitment to a Sustainable Future
Access U.S.-based high quality chemical toxicology study execution, supported by in-state regulatory experts, to increase scheduling options.
